April 7, 2022 | By Haley Wilson | Clinical Trials, Liver Disease, Minority Participation in Liver Research | Blog, Diversity in research, Fatty Liver Disease, NAFLD, NASH, National Minority Health Month
April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that affect people from racial and ethnic minority groups. Liver disease is growing in prevalence in the Hispanic population. It is also a leading cause …
March 7, 2022 | By Haley Wilson | Fibroscan, Liver Disease | Blog, NAFLD, NASH, Women's History Month
March is Women’s History Month, and it commemorates women’s contributions to history, culture, and society. The 2022 theme is “Women Providing Healing, Promoting Hope.” It is a tribute to the countless ways women of all cultures provide healing and hope …
August 26, 2021 | By Haley Wilson | Cirrhosis, Clinical Trials, Liver Disease | Blog, NAFLD, NASH
Cirrhosis is when the permanent scarring of the liver has replaced the healthy tissue. While cirrhosis is most often associated with chronic alcohol consumption, it is brought about by many types of liver disease. Here’s how you get from liver disease …
August 4, 2021 | By Haley Wilson | Clinical Trials, Liver Disease | Blog, Caregiving, Clinical research, NAFLD, NASH
Having liver disease affects the person with it but also loved ones around them. Often a family member or friend fills the role of meeting a variety of physical and emotional needs. If you are a caregiver for someone with …
July 13, 2021 | By Haley Wilson | Clinical Trials, Liver Disease | Blog, Clinical trials, NAFLD, NASH
The number of U.S. adults with non-alcoholic fatty liver disease (NAFLD) currently sits around 25%. Approximately 2-3% of them will go on to develop non-alcoholic steatohepatitis (NASH). NASH is a more severe form of NAFLD and can lead to fibrosis, …